Lv4
412 积分 2021-10-28 加入
Bone health in cancer: ESMO Clinical Practice Guidelines
7天前
已完结
American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer
7天前
已完结
Bone Health Outcomes from the International, Multicenter, Randomized, Phase 3, Placebo-Controlled D-CARE Study Assessing Adjuvant Denosumab in Early Breast Cancer
7天前
已完结
Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer
8天前
已完结
Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
8天前
已完结
A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer
10天前
已完结
Efficacy and safety of same-day versus next-day administration of PEG-rhG-CSF for the prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia in patients with breast cancer: a retrospective cohort study
10天前
已完结
The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignancies
10天前
已完结
Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non-Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Four Multicenter, Double-Blind, Randomized Phase II Studies
10天前
已完结
Safety and efficacy of same-day administration of eflapegrastim in patients with early-stage breast cancer receiving chemotherapy
10天前
已完结
皖公网安备34019202002308
